product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
other
product name :
alamarBlue®
catalog :
BUF012B
quantity :
100 ml
price :
416 USD
more info or order :
Bio-Rad product webpage
citations: 22
Reference
Tsai H, IJspeert C, Shen A. Voltage-gated ion channels mediate the electrotaxis of glioblastoma cells in a hybrid PMMA/PDMS microdevice. APL Bioeng. 2020;4:036102 pubmed publisher
Fu T, Kuo P, Lu Y, Lin H, Wang L, Lin Y, et al. Cell Penetrating Peptide as a High Safety Anti-Inflammation Ingredient for Cosmetic Applications. Biomolecules. 2020;10: pubmed publisher
Mayers S, Moço P, Maqbool T, Silva P, Kilkenny D, Audet J. Establishment of an erythroid progenitor cell line capable of enucleation achieved with an inducible c-Myc vector. BMC Biotechnol. 2019;19:21 pubmed publisher
Windpassinger C, Piard J, Bonnard C, Alfadhel M, Lim S, Bisteau X, et al. CDK10 Mutations in Humans and Mice Cause Severe Growth Retardation, Spine Malformations, and Developmental Delays. Am J Hum Genet. 2017;101:391-403 pubmed publisher
Jia D, Li L, Andrew S, Allan D, Li X, Lee J, et al. An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells. Cell Death Dis. 2017;8:e2932 pubmed publisher
Jain S, Jacob M, Walker L, Tekwani B. Screening North American plant extracts in vitro against Trypanosoma brucei for discovery of new antitrypanosomal drug leads. BMC Complement Altern Med. 2016;16:131 pubmed publisher
Hsu F, Chen T, Chuang H, Chang Y, Hwang J. Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice. Oncotarget. 2015;6:44134-50 pubmed publisher
Pellegrini C, Columbaro M, Capanni C, D Apice M, Cavallo C, Murdocca M, et al. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype. Oncotarget. 2015;6:29914-28 pubmed publisher
Vishnubalaji R, Hamam R, Abdulla M, Mohammed M, Kassem M, Al Obeed O, et al. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer. Cell Death Dis. 2015;6:e1614 pubmed publisher
Garcia V, Krishnan R, Davis C, Batenchuk C, Le Boeuf F, Abdelbary H, et al. High-throughput titration of luciferase-expressing recombinant viruses. J Vis Exp. 2014;:51890 pubmed publisher
Huang S, Lee C, Wang H, Chang Y, Lin C, Chen C, et al. 6-Dehydrogingerdione restrains lipopolysaccharide-induced inflammatory responses in RAW 264.7 macrophages. J Agric Food Chem. 2014;62:9171-9 pubmed publisher
Jiang P, Mukthavaram R, Chao Y, Nomura N, Bharati I, Fogal V, et al. In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells. Br J Cancer. 2014;111:1562-71 pubmed publisher
Pingle S, Sultana Z, Pastorino S, Jiang P, Mukthavaram R, Chao Y, et al. In silico modeling predicts drug sensitivity of patient-derived cancer cells. J Transl Med. 2014;12:128 pubmed publisher
Koukourakis M, Giatromanolaki A, Panteliadou M, Pouliliou S, Chondrou P, Mavropoulou S, et al. Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy. Br J Cancer. 2014;110:2217-23 pubmed publisher
Wang C, Ma N, Lin Y, Wu C, Wu H, Yu C, et al. Array-based high-throughput screening in mouse embryonic stem cells with shRNAs. Curr Protoc Stem Cell Biol. 2013;26:Unit 5C.3. pubmed publisher
Jiang P, Mukthavaram R, Mukthavavam R, Chao Y, Bharati I, Fogal V, et al. Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs. J Transl Med. 2014;12:13 pubmed publisher
Zimmermann E, da Silva L, Calegari G, Stamm F, Souto R, Dalmora S. Development and validation of a stability-indicating size-indicating size-exclusion LC method for the determination of rhIFN-alpha2a in pharmaceutical formulations. J AOAC Int. 2013;96:324-30 pubmed
Han J, Farah S, Domb A, Lelkes P. Electrospun rapamycin-eluting polyurethane fibers for vascular grafts. Pharm Res. 2013;30:1735-48 pubmed publisher
Keenan J, Joyce H, Aherne S, O Dea S, Doolan P, Lynch V, et al. Olfactomedin III expression contributes to anoikis-resistance in clonal variants of a human lung squamous carcinoma cell line. Exp Cell Res. 2012;318:593-602 pubmed publisher
Robinson H, Markaki A, Collier C, Clyne T. Cell adhesion to plasma electrolytic oxidation (PEO) titania coatings, assessed using a centrifuging technique. J Mech Behav Biomed Mater. 2011;4:2103-12 pubmed publisher
Landgraf K, Santell L, Billeci K, Quan C, Young J, Maun H, et al. Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling. J Biol Chem. 2010;285:40362-72 pubmed publisher
Silva M, Lamarre B, Cerasoli E, Rakowska P, Hills A, Bailey M, et al. Physicochemical and biological assays for quality control of biopharmaceuticals: interferon alpha-2 case study. Biologicals. 2008;36:383-92 pubmed publisher
image
image 1 :
Bio-Rad BUF012B image 1
alamarBlue ® indicator dye (BUF012B) quantitatively measures proliferation in human, animal, bacterial, fungal and mycobacterial cells. It is useful for cytokine bioassays, cell proliferation studies and in-vitro cytotoxicity determinations as well as cell growth monitoring
product information
Entity Type :
Accessory Reagent
Entity Category :
Other Reagents
ProductCode :
BUF012B
Description :
alamarBlue®
Specificity :
alamarBlue®
Format :
Reagent
Applications :
E,FN,IF
ApplicationTypes :
ELISA,Functional Assays,Immunofluorescence
Quantity :
100 ml
Quantity Value :
100
Quantity Type :
ml
Entity Formats :
Reagent
UNSPSC :
41116126
Product Form :
Liquid
PriceGBP :
314
PriceEUR :
466
PriceUSD :
416 USD
PriceCHF :
507
PriceSEK :
5079
PriceNOK :
5105
PriceDKK :
3474
more info or order :
Bio-Rad product webpage
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.